Long-Acting Poly(DL:Lactic Acid-Castor Oil) 3:7-Bupivacaine Formulation: Effect of Hydrophobic Additives
- 30 June 2011
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 28 (12) , 3265-3273
Abstract
To reduce formulation viscosity of bupivacaine/poly(DL lactic acid co castor oil) 3:7 without increasing bupivacaine release rates. Poly(DL lactic acid) 3:7 was synthesized and bupivacaine formulation prepared by mixing with additives ricinoleic acid or castor oil. In vitro release measurements identified optimum formulation. Anesthetized ICR mice were injected around left sciatic nerve using nerve stimulator with 0.1 mL of formulation. Animals received 10% bupivacaine-polymer formulation with 10% castor oil (p(DLLA:CO)3:7–10% bupi-10% CO) or 15% bupivacaine-polymer with 10% castor oil (p(DLLA:CO)3:7–15% bupi-10% CO). Sensory and motor block were measured. Viscosity of 10% and 15% bupivacaine-p(DLLA:CO)3:7 formulations was reduced using hydrophobic additives; however, castor oil reduced bupivacaine release rates and eliminated burst effect. Less than 10% of the incorporated bupivacaine was released during 6 h, and less than 25% released in 24 h in vitro. In vivo formulation injection resulted in a 24 h motor block and a sensory block lasting at least 72 h. Incorporation of hydrophobic low-viscosity additive reduced viscosity in addition to burst release effects. Bupivacaine-polymer formulation with castor oil additive demonstrated prolonged sensory analgesia in vivo, with reduced duration of motor block.Keywords
This publication has 32 references indexed in Scilit:
- Poly(dl:Lactic Acid-Castor Oil) 3:7-Bupivacaine Formulation: Reducing Burst Effect Prolongs Efficacy In VivoJournal of Pharmaceutical Sciences, 2010
- A Pre-Emptive Multimodal Pathway Featuring Peripheral Nerve Block Improves Perioperative Outcomes After Major Orthopedic SurgeryRegional Anesthesia & Pain Medicine, 2008
- Assessment of Drug Release from Oil Depot Formulations Using an In Vitro Model—Potential Applicability in Accelerated Release TestingDrug Development and Industrial Pharmacy, 2008
- Long acting local anesthetic–polymer formulation to prolong the effect of analgesiaJournal of Controlled Release, 2007
- Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel—effect of additivesJournal of Controlled Release, 2005
- Injectable microparticle–gel system for prolonged and localized lidocaine release. II. in vivo anesthetic effectsJournal of Biomedical Materials Research Part A, 2004
- Poly(sebacic acid‐co‐ricinoleic acid) biodegradable carrier for paclitaxel: In vitro release and in vivo toxicityJournal of Biomedical Materials Research Part A, 2004
- Effect of excipient composition on the biocompatibility of bupivacaine‐containing microparticles at the sciatic nerveJournal of Biomedical Materials Research Part A, 2004
- Toxicity of Bupivacaine Encapsulated into Liposomes and Injected IntravenouslyAnesthesia & Analgesia, 1993
- A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesiaPain, 1988